Cargando…

Prediction of lymph node metastasis in early esophageal cancer

BACKGROUND: Given the poor prognosis of patients with lymph node metastasis, estimating the lymph node status in patients with early esophageal cancer is crucial. Indicators that could be used to predict lymph node metastasis in early esophageal cancer have been reported in many recent studies, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Wang, Jun-Xiong, Yibi, Ran-Hen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642458/
https://www.ncbi.nlm.nih.gov/pubmed/37969711
http://dx.doi.org/10.4240/wjgs.v15.i10.2294
_version_ 1785146972877881344
author Li, Yan
Wang, Jun-Xiong
Yibi, Ran-Hen
author_facet Li, Yan
Wang, Jun-Xiong
Yibi, Ran-Hen
author_sort Li, Yan
collection PubMed
description BACKGROUND: Given the poor prognosis of patients with lymph node metastasis, estimating the lymph node status in patients with early esophageal cancer is crucial. Indicators that could be used to predict lymph node metastasis in early esophageal cancer have been reported in many recent studies, but no recent studies have included a review of this subject. AIM: To review indicators predicting lymph node metastasis in early esophageal squamous cell carcinoma (ESCC) and early esophageal adenocarcinoma (EAC). METHODS: We searched PubMed with “[early esophageal cancer (Title/Abstract)] and [lymph node (Title/Abstract)]” or “[early esophageal carcinoma (Title/Abstract)] and [lymph node (Title/Abstract)]” or “[superficial esophageal cancer (Title/Abstract)] and [lymph node (Title/Abstract)].” A total of 29 studies were eligible for analysis. RESULTS: Preoperative imaging (size), serum markers (microRNA-218), postoperative pathology and immunohistochemical analysis (depth of invasion, tumor size, differentiation grade, lymphovascular invasion, neural invasion, expression of PIM-1 < 30%) were predictive factors for lymph node metastasis in both early ESCC and EAC. Serum markers (thymidine kinase 1 ≥ 3.38 pmol/L; cytokeratin 19 fragment antigen 21-1 > 3.30 ng/mL; stathmin-1) and postoperative pathology and immunohistochemical analysis (overexpression of cortactin, mixed-lineage leukaemia 2, and stanniocalcin-1) were predictive for lymph node metastasis in early ESCC. Transcription of CD69, myeloid differentiation protein 88 and toll-like receptor 4 and low expression of olfactomedin 4 were predictive of lymph node metastasis in early EAC. A total of 6 comprehensive models for early ESCC, including logistic regression model, nomogram, and artificial neural network (ANN), were reviewed. The areas under the receiver operating characteristic curve of these models reached 0.789-0.938, and the ANN performed best. As all these models relied on postoperative pathology, further models focusing on serum markers, imaging and immunohistochemical indicators are still needed. CONCLUSION: Various factors were predictive of lymph node metastasis in early esophageal cancer, and present comprehensive models predicting lymph node metastasis in early ESCC mainly relied on postoperative pathology. Further studies focusing on serum markers, imaging and immunohistochemical indicators are still in need.
format Online
Article
Text
id pubmed-10642458
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-106424582023-11-15 Prediction of lymph node metastasis in early esophageal cancer Li, Yan Wang, Jun-Xiong Yibi, Ran-Hen World J Gastrointest Surg Systematic Reviews BACKGROUND: Given the poor prognosis of patients with lymph node metastasis, estimating the lymph node status in patients with early esophageal cancer is crucial. Indicators that could be used to predict lymph node metastasis in early esophageal cancer have been reported in many recent studies, but no recent studies have included a review of this subject. AIM: To review indicators predicting lymph node metastasis in early esophageal squamous cell carcinoma (ESCC) and early esophageal adenocarcinoma (EAC). METHODS: We searched PubMed with “[early esophageal cancer (Title/Abstract)] and [lymph node (Title/Abstract)]” or “[early esophageal carcinoma (Title/Abstract)] and [lymph node (Title/Abstract)]” or “[superficial esophageal cancer (Title/Abstract)] and [lymph node (Title/Abstract)].” A total of 29 studies were eligible for analysis. RESULTS: Preoperative imaging (size), serum markers (microRNA-218), postoperative pathology and immunohistochemical analysis (depth of invasion, tumor size, differentiation grade, lymphovascular invasion, neural invasion, expression of PIM-1 < 30%) were predictive factors for lymph node metastasis in both early ESCC and EAC. Serum markers (thymidine kinase 1 ≥ 3.38 pmol/L; cytokeratin 19 fragment antigen 21-1 > 3.30 ng/mL; stathmin-1) and postoperative pathology and immunohistochemical analysis (overexpression of cortactin, mixed-lineage leukaemia 2, and stanniocalcin-1) were predictive for lymph node metastasis in early ESCC. Transcription of CD69, myeloid differentiation protein 88 and toll-like receptor 4 and low expression of olfactomedin 4 were predictive of lymph node metastasis in early EAC. A total of 6 comprehensive models for early ESCC, including logistic regression model, nomogram, and artificial neural network (ANN), were reviewed. The areas under the receiver operating characteristic curve of these models reached 0.789-0.938, and the ANN performed best. As all these models relied on postoperative pathology, further models focusing on serum markers, imaging and immunohistochemical indicators are still needed. CONCLUSION: Various factors were predictive of lymph node metastasis in early esophageal cancer, and present comprehensive models predicting lymph node metastasis in early ESCC mainly relied on postoperative pathology. Further studies focusing on serum markers, imaging and immunohistochemical indicators are still in need. Baishideng Publishing Group Inc 2023-10-27 2023-10-27 /pmc/articles/PMC10642458/ /pubmed/37969711 http://dx.doi.org/10.4240/wjgs.v15.i10.2294 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Systematic Reviews
Li, Yan
Wang, Jun-Xiong
Yibi, Ran-Hen
Prediction of lymph node metastasis in early esophageal cancer
title Prediction of lymph node metastasis in early esophageal cancer
title_full Prediction of lymph node metastasis in early esophageal cancer
title_fullStr Prediction of lymph node metastasis in early esophageal cancer
title_full_unstemmed Prediction of lymph node metastasis in early esophageal cancer
title_short Prediction of lymph node metastasis in early esophageal cancer
title_sort prediction of lymph node metastasis in early esophageal cancer
topic Systematic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642458/
https://www.ncbi.nlm.nih.gov/pubmed/37969711
http://dx.doi.org/10.4240/wjgs.v15.i10.2294
work_keys_str_mv AT liyan predictionoflymphnodemetastasisinearlyesophagealcancer
AT wangjunxiong predictionoflymphnodemetastasisinearlyesophagealcancer
AT yibiranhen predictionoflymphnodemetastasisinearlyesophagealcancer